CorMedix Inc (CRMD) is a biotechnology company listed on US.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Use this CRMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRMD SEC filings page. Lician reads the product cache first so this HTML stays unique to CorMedix Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CRMD income, balance, and cash tables.